Patent · US Active

Antibody-nanoparticle conjugates and methods for making and using such conjugates

US9040310B2 · kind B2 · utility

12Cited by
12References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2011
Grant dateMay 26, 2015
Priority date
Expiry dateJul 15, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/916
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Disclosed herein are antibody-nanoparticle conjugates that include two or more nanoparticles (such as gold, palladium, platinum, silver, copper, nickel, cobalt, iridium, or an alloy of two or more thereof) directly linked to an antibody or fragment thereof through a metal-thiol bond. Methods of making the antibody-nanoparticle conjugates disclosed herein include reacting an arylphosphine-nanoparticle composite with a reduced antibody to produce an antibody-nanoparticle conjugate. Also disclosed herein are methods for detecting a target molecule in a sample that include using an antibody-nanoparticle conjugate (such as the antibody-nanoparticle conjugates described herein) and kits for detecting target molecules utilizing the methods disclosed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.